Utah Medical Products UTMD Stock Option Plan Expense
Stock Option Plan Expense at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:StockOptionPlanExpense.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's stock option plan expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's stock option plan expense?
- Utah Medical Products (UTMD) reported stock option plan expense of $120K in Q1 2026.
- How has Utah Medical Products's stock option plan expense changed year-over-year?
- Utah Medical Products's stock option plan expense increased by 46.3% year-over-year, from $82K to $120K.
- What is the long-term trend for Utah Medical Products's stock option plan expense?
- Over 4 years (2021 to 2025), Utah Medical Products's stock option plan expense has grown at a 22.5% compound annual growth rate (CAGR), from $166K to $374K.
- What does stock option plan expense mean?
- This metric quantifies the non-cash compensation expense recognized in the income statement related to stock options granted to employees and directors. It is calculated based on the fair value of the options at the grant date, amortized over the vesting period. This figure is essential for understanding the true cost of human capital and the potential for future share dilution.